Neogen in deal with Merck to market Heifer genome testing; Jaguar starts new product application for dogs; Studer named VP at IDEXX;

> Neogen says it reached an agreement with Merck Animal Health ($MRK) to market Neogen's Igenity Dairy Heifer Program that uses genomic testing to help identify the potential of replacement dairy heifers. Announcement

> Jaguar Animal Health says it has begun a new product application for a treatment for insulin resistance and metabolic syndrome in dogs. Announcement

> IDEXX Laboratories ($IDXX) named Jacqueline Studer as corporate vice president, general counsel and secretary in charge of the company's legal, compliance, regulatory affairs and quality assurance groups. Announcement

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…